CoChat

Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study

Martin, Jack L., Fry, Edward T.A., Sanderink, Ger‐Jan C.M., Atherley, Trevor H., Guimart, Colette M., Chevalier, Paul J., Ozoux, Marie‐Laure, Pensyl, Catherine E., Bigonzi, Frederique · 2004 · Catheterization and Cardiovascular Interventions
Cited by 77

The DOI matches its Crossref record.

Abstract

The objective of this study was to evaluate the pharmacokinetic response to intravenous (IV) enoxaparin given 8–12 hr after subcutaneous (SC) dosing in patients undergoing percutaneous coronary intervention (PCI). Fifty‐five patients received SC enoxaparin (1 mg/kg every 12 hr) followed by an IV bolus (0.3 mg/kg) 8–12 hr after the last SC dose, at the start of PCI or during catheterization. Anti‐Xa levels were within the target range in 98% of patients 2–8 hr after the last SC dose, in 96% of patients following the IV bolus, and in 91% of patients for a further 2 hr. Subcutaneous enoxaparin (1 mg/kg every 12 hr) provides sufficient anti‐Xa levels for PCI 2–8 hr after the last dose. An additional 0.3 mg/kg enoxaparin dose given IV 8–12 hr after the last SC dose reliably maintains anti‐Xa levels within the target for at least 2 additional hr. Catheter Cardiovasc Interv 2004;61:163–170. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ccd.10726

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 77

Metadata

Authors
Martin, J. L., Fry, E. T. A., Sanderink, G. C. M., Atherley, T. H., Guimart, C. M., Chevalier, P. J., Ozoux, M., Pensyl, C. E., & Bigonzi, F.
Venue
Catheterization and Cardiovascular Interventions
Publisher
Wiley
Published
2004-01-23
Volume
61
Issue
2
Pages
163-170
ISSN
  • 1522-1946 (ISSN-L)
  • 1522-726X
OpenAlex
W2101996111
Cited by
77
References
0
FWCI
4.53
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study. https://app.cochat.ai/papers/10.1002/ccd.10726
The paper
Martin, J. L., Fry, E. T. A., Sanderink, G. C. M., Atherley, T. H., Guimart, C. M., Chevalier, P. J., Ozoux, M., Pensyl, C. E., & Bigonzi, F. (2004). Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.10726

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.